EGFR–TKI tumour response predicts NSCLC survival

A partial or complete response to epidermal growth factor receptor tyrosine kinase inhibitor therapy is significantly associated with survival in patients with non-small-cell lung cancer, research suggests.
Source: MedWire News - Oncology - Category: Cancer & Oncology Source Type: news